ライフサイエンスコーパス: immunoglobulin E

1 DEIA groups, except for level of total serum immunoglobulin E.

2 mpaired in mastocytosis or allergen-specific immunoglobulin E.

3 r "aptamer" designed to bind specifically to immunoglobulin E.

4 d by T helper type 2 cytokines and increased immunoglobulin E.

5 high levels of interleukin (IL)-5, IL-4, and immunoglobulin E.

6 n 5 in the lung, and reduced serum levels of immunoglobulin E.

7 s to common allergens, which are mediated by immunoglobulin E.

8 rface expression by a 4-d preincubation with immunoglobulin E.

9 lergic inflammation, as measured by elevated immunoglobulin E.

10 rmalized circulating levels of cytokines and immunoglobulin E.

11 lycerides,.37; diastolic blood pressure,.21; immunoglobulin E,.63; lipoprotein(a),.77; and body-mass

12 of airway medication, blood eosinophils, and immunoglobulin E (adjusted OR [aOR], 3.56 [95% CI, 2.51-

13 Serum immunoglobulin E against eight common inhalant and six f

14 sensitization by specific serum antibodies (immunoglobulin E) against aero-allergens.

15 aggregation of Fc epsilon RI receptors with immunoglobulin E and antigen is mediated through the act

16 Specific immunoglobulin E and bronchial hyper-responsiveness were

17 asthma phenotypes, such as high total serum immunoglobulin E and bronchial hyperresponsiveness, have

18 tors, including interleukin-5 (IL-5), IL-13, immunoglobulin E and eosinophils.

19 of asthma in a manner that is independent of immunoglobulin E and eosinophils.

20 Total serum immunoglobulin E and FEV1 predicted levels were not asso

21 We measured specific immunoglobulin E and G4 directed to recombinant A. fumig

22 -alpha-treated mice exhibited elevated serum immunoglobulin E and inhibition of the anticryptococcal

23 Immunoglobulin E and its interactions with receptors FcR

24 oded nanopores to detect single molecules of immunoglobulin E and the bioterrorist agent ricin, seque

25 h2 response was accompanied by production of immunoglobulin E and the sensitization of circulating ba

26 eutic approaches, including the targeting of immunoglobulin E and tumour necrosis factor alpha with b

27 a mutant deficient in delta-toxin, promoted immunoglobulin-E and interleukin-4 production, as well a

28 amers against a surface-immobilized protein (immunoglobulin E) and a solution-phase small molecule (b

29 with asthma, AHR, lung function, total serum immunoglobulin E, and blood eosinophil levels.

30 Th2 cell skewing was dependent on basophils, immunoglobulin E, and interleukin-4, but was independent

31 terleukin-5 (IL-5), IL-13, gamma interferon, immunoglobulin E, and mucus-secreting cells.

32 Aptamers for human alpha-thrombin, immunoglobulin E, and platelet-derived growth factor B w

33 e function and development, such as allergy, immunoglobulin E, and Varicella infection status.

34 Anti-immunoglobulin E (anti-IgE) (omalizumab), a humanized mo

35 at year 1 and repeated assessments of serum immunoglobulin E antibodies (year 1, 4.5, 6), atopic der

36 xpectedly, FcgammaRIV 'preferentially' bound immunoglobulin E antibodies of the 'b' allotype (IgE(b))

37 allergens in home dust samples, and specific immunoglobulin E antibodies were measured at outset, and

38 ex sensitization (measured by latex-specific immunoglobulin E antibodies) by using data from 5,512 ad

39 intradermal injections of anti-dinitrophenyl immunoglobulin E antibodies.

40 rotocol including measurement of HE-specific immunoglobulin E-antibodies in serum, skin prick tests,

41 The human immunoglobulin E antibody responses to the group 1 aller

42 test positivity (SPT), and allergen-specific immunoglobulin E (asIgE) after 3 years of intervention.

43 e poor correlation between allergen-specific immunoglobulin E (asIgE) and clinical signs of allergy i

44 fector cells in allergic disorders and other immunoglobulin E-associated acquired immune responses th

45 on as effector and immunoregulatory cells in immunoglobulin E-associated allergic disorders, as well

46 -6, CXCL8), IL-12, CCL11, thromboxane B2 and immunoglobulin E at 24 h after local allergen challenge.

47 RI subunits for the formation of functional, immunoglobulin E-binding FcepsilonRI complexes during en

48 n-specific T-cell responses by internalizing immunoglobulin E-bound antigens for presentation to anti

49 Cross-linking of immunoglobulin E-bound FcepsilonRI triggers multiple cel

50 erin ectodomains fused to the Fc fragment of immunoglobulin (E-cad/Fc, N-cad/Fc, and P-cad/Fc) and im

51 llergen specificity, allergen-specific serum immunoglobulin E concentration, or individual laboratory

52 Allergen-specific serum immunoglobulin E concentrations ranged from 0.1 to 100 k

53 +)) influx; however, unlike that mediated by immunoglobulin-E crosslinking, it did not require the sp

54 49B1 is expressed on mast cells and inhibits immunoglobulin E-dependent activation and inflammation i

55 ved in the recruitment of neutrophils during immunoglobulin E-dependent gastric inflammation in the m

56 Immunoglobulin E-dependent gastric inflammation is chara

57 s can exacerbate ADHD symptoms and cause non-immunoglobulin E-dependent histamine release from circul

58 were increased in gastric tissues undergoing immunoglobulin E-dependent inflammation.

59 ond important action of ISS is inhibition of immunoglobulin E-dependent release of Th2 cytokines, esp

60 The high affinity receptor for immunoglobulin E (designated Fc epsilon RI) is the membe

61 Allergen-specific serum immunoglobulin E detection and quantification have becom

62 andard was carried out for allergen-specific immunoglobulin E determination using the fluoroimmunoenz

63 Allergen-specific serum immunoglobulin E determination with the fluoroimmunoenzy

64 kin tests and measurement of serum levels of immunoglobulin E do not accurately identify foods for el

65 In addition, immunoglobulin-E enhanced delta-toxin-induced mast cell

66 otal immunoglobulin E (TIgE), serum-specific immunoglobulin E, eosinophil count in peripheral blood,

67 osslinking of the high-affinity receptor for immunoglobulin E, F(c)epsilonRI.

68 Aggregation of high-affinity receptors for immunoglobulin E (Fc epsilon RI) on the surface of mast

69 aling through the high affinity receptor for immunoglobulin E (Fc epsilon RI) results in the coordina

70 ss-linking of the high-affinity receptor for immunoglobulin E (FcepsilonRI) results in release of inf

71 ss-linking of the high-affinity receptor for immunoglobulin E (FcepsilonRI).

72 rough their receptors with high affinity for immunoglobulin E (FcepsilonRI).

73 n mediated by the high-affinity receptor for immunoglobulin E, FcepsilonRI, but the molecular basis i

74 he A-B loop of the Cepsilon3 domain of human immunoglobulin E has been carried out.

75 llergens by skin prick and allergen-specific immunoglobulin E (IgE) (ImmunoCAP((R))) tests.

76 associated with increased allergen-specific immunoglobulin E (IgE) against a range of environmental

77 We measured specific Immunoglobulin E (IgE) against prevalent allergens and g

78 etecting human immunoglobulin G (IgG), human immunoglobulin E (IgE) and Aspergillus fumigatus antibod

79 ory-like', increased serum concentrations of immunoglobulin E (IgE) and caused dendritic cells to pro

80 d candidate genes for association with total immunoglobulin E (IgE) and effect modification by 25-hyd

81 -5 and IL-13, which induce the production of immunoglobulin E (IgE) and eosinophils [1,2].

82 cells express the high-affinity receptor for immunoglobulin E (IgE) and have been linked to host defe

83 mastocytosis and the production of both the immunoglobulin E (IgE) and IgG1 isotypes.

84 About 20 years after the identification of immunoglobulin E (IgE) and its key role in allergic hype

85 , this treatment increases parasite-specific immunoglobulin E (IgE) and other Th2 responses in the mo

86 s, characterized by increases in total serum immunoglobulin E (IgE) and specific serum IgG1 levels an

87 Immunoglobulin E (IgE) antibodies and mast cells have be

88 Immunoglobulin E (IgE) antibodies are a characteristic f

89 Immunoglobulin E (IgE) antibodies are known for triggeri

90 Immunoglobulin E (IgE) antibodies are pathogenic in asth

91 isdirected type 2 immune responses, in which immunoglobulin E (IgE) antibodies are produced against a

92 Immunoglobulin E (IgE) antibodies play a fundamental rol

93 Exposure to allergens crosslinks immunoglobulin E (IgE) antibodies that are bound to mast

94 In particular, the immunoglobulin E (IgE) antibody response to the carbohyd

95 The monoclonal anti-immunoglobulin E (IgE) antibody, omalizumab, was the fir

96 nsor, featuring a highly specific anti-human immunoglobulin E (IgE) aptamer as a capture probe, for h

97 isks) and to assess the oxaliplatin-specific immunoglobulin E (IgE) as a novel diagnostic tool.

98 he first to report high levels of functional immunoglobulin E (IgE) autoantibodies recognizing brain

99 To elucidate the immunoglobulin E (IgE) binding epitopes in the linear se

100 ne if D-amino acids (D-aas) bind and inhibit immunoglobulin E (IgE) binding to peanut allergens.

101 ), stably cross-links anti-2,4-dinitrophenyl-immunoglobulin E (IgE) bound to high affinity receptors

102 n: FM by plethysmography, total and specific immunoglobulin E (IgE) by automated immunosorbent analys

103 everal extracellular cues, including antigen-immunoglobulin E (IgE) complexes, bacteria, viruses, cyt

104 While serum immunoglobulin E (IgE) concentration has been shown to b

105 Framingham Heart Study data on total plasma immunoglobulin E (IgE) concentrations and found a number

106 nts stimulated by the mast cell receptor for immunoglobulin E (IgE) correlated with the affinity of a

107 Immunoglobulin E (IgE) exhibits a uniquely high affinity

108 Adoptive transfer of allergen-specific immunoglobulin E (IgE) from atopic donors to nonatopic r

109 Immunoglobulin E (IgE) has a major role in the pathogene

110 gths (I) on allergen extractability from and immunoglobulin E (IgE) immunoreactivity of peanut, almon

111 ctivated B lymphocyte increases the level of immunoglobulin E (IgE) in a protein kinase A (PKA)- and

112 Despite the critical role of immunoglobulin E (IgE) in allergy, circulating IgE+ B ce

113 n of low concentrations of allergen-specific Immunoglobulin E (IgE) in human sera using a Photonic Cr

114 itative immunoassay for the determination of immunoglobulin E (IgE) in human serum using gold nanoclu

115 activation of the high-affinity receptor for immunoglobulin E (IgE) in mast cells.

116 high-affinity Fc receptor (FcepsilonRI) for immunoglobulin E (IgE) in MC/9 mouse mast cells stimulat

117 Capture and detection of immunoglobulin E (IgE) in simple solution and in human s

118 lper (Th) 2 cells, the physiological role of immunoglobulin E (IgE) in the airway remains largely und

119 Immunoglobulin E (IgE) is a central mediator of allergic

120 Serum total immunoglobulin E (IgE) is a critical intermediate phenot

121 Immunoglobulin E (IgE) is believed to be one of the majo

122 The authors investigated if cord blood immunoglobulin E (IgE) is dependent upon birth order and

123 r-based biosensor for the detection of human immunoglobulin E (IgE) is developed using the electroche

124 Immunoglobulin E (IgE) is important in mediating human a

125 Immunoglobulin E (IgE) is pathogenic in allergic disease

126 mucosal tissues of allergic reactions, where immunoglobulin E (IgE) is produced locally.

127 Immunoglobulin E (IgE) is well known for its role in all

128 B cells expressing antibodies of the immunoglobulin E (IgE) isotype are rare, yet are heavily

129 antibody levels revealed an increase in the immunoglobulin E (IgE) level in immunized mice.

130 and no significant elevation in the systemic immunoglobulin E (IgE) level.

131 Elevated serum Immunoglobulin E (IgE) levels and increased airway respo

132 study examined the association between serum immunoglobulin E (IgE) levels for a panel of common indo

133 rhinitis, and itchy rash) and serum-specific immunoglobulin E (IgE) levels from the 2005-2006 Nationa

134 Comparison of OVA-specific immunoglobulin E (IgE) levels in the serum and numbers o

135 Cytokines, chemokines, and total immunoglobulin E (IgE) levels were measured using immuno

136 Total serum immunoglobulin E (IgE) levels were significantly lower i

137 ry, maternal and paternal total and specific Immunoglobulin E (IgE) levels, and cord blood IgE were r

138 erresponsiveness (BHR), elevated total serum immunoglobulin E (IgE) levels, and skin tests positive t

139 ed based on increased IL-5 production, total immunoglobulin E (IgE) levels, antigen-specific IgG1 res

140 f intermediate phenotypes, one each on serum immunoglobulin E (IgE) levels, blood eosinophil counts a

141 Total serum immunoglobulin E (IgE) levels, for example, show strong

142 Canonically, immunoglobulin E (IgE) mediates allergic immune response

143 Immunoglobulin E (IgE) mediates its effector functions v

144 Immunoglobulin E (IgE) mediates many of the inflammatory

145 estigated how the high-affinity receptor for immunoglobulin E (IgE) modulates the response of mast ce

146 ceptor for the Fc region of antigen-specific immunoglobulin E (IgE) molecules.

147 acebo-controlled clinical trials of the anti-immunoglobulin E (IgE) monoclonal antibody, rhuMAb-E25 (

148 e current study, we used omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, to demonstra

149 ividuals is that parasite-induced polyclonal immunoglobulin E (IgE) out-competes allergen-specific Ig

150 omosome 14q was screened for loci modulating immunoglobulin E (IgE) phenotypes in 15 extended and 45

151 ing the serum of the patient showed specific immunoglobulin E (IgE) positivity for wasps; therefore,

152 cell type 2 (Th2) responses leading to hyper-immunoglobulin E (IgE) production and allergy.

153 as suggested an increase in antigen-specific immunoglobulin E (IgE) production during viral infection

154 draining lymph node (DLN) cell infiltrates, immunoglobulin E (IgE) production, and airway hyper-resp

155 igated the relationship between the specific immunoglobulin E (IgE) profile for 40 allergens using a

156 This study analysed Immunoglobulin E (IgE) profiles to single allergen compo

157 Cross-linkage of the high-affinity immunoglobulin E (IgE) receptor (FcvarepsilonRI) on mast

158 tiated by cross-linking of the high-affinity immunoglobulin E (IgE) receptor FcepsilonRI.

159 abilities, we analyzed a published model for immunoglobulin E (IgE) receptor signaling using syntheti

160 The low-affinity immunoglobulin E (IgE) receptor, CD23 (FcepsilonRII), bi

161 and basophils that express the high-affinity immunoglobulin E (IgE) receptor, Fc epsilon receptor 1 (

162 ates upon cross-linking of the high-affinity immunoglobulin E (IgE) receptor.

163 ROSA(KIT WT), expressing a fully functional immunoglobulin E (IgE) receptor.

164 Targeting of immunoglobulin E (IgE) represents an interesting approac

165 Specific immunoglobulin E (IgE) responses are upregulated during

166 by which allergic patients develop specific immunoglobulin E (IgE) responses to environmental allerg

167 Cross-linking of high-affinity immunoglobulin E (IgE) results in the life-threatening a

168 he basis of immune deviation that results in immunoglobulin E (IgE) sensitization and allergic reacti

169 Assessing immunoglobulin E (IgE) sensitization to allergens is an

170 ociated with concomitant atopic diseases and immunoglobulin E (IgE) sensitization to food allergens i

171 gher baseline levels of schistosome-specific immunoglobulin E (IgE) than did children with > or =2 re

172 The binding of immunoglobulin E (IgE) to high affinity IgE receptors (F

173 s is reported for the sensitive detection of immunoglobulin E (IgE) using fluorescence polarization (

174 isease and asthma, and more than 30 yr since immunoglobulin E (IgE) was identified as the key molecul

175 nce and binding properties of an aptamer for immunoglobulin E (IgE) was investigated using custom DNA

176 ns at the site of infection and infection of immunoglobulin E (IgE)(-/-) mice, lead us to suggest tha

177 gnificant reduction in STH prevalence, total immunoglobulin E (IgE), and eosinophil count.

178 CD4-CD8- peripheral T cells, elevated serum immunoglobulin E (IgE), and possible pulmonary inflammat

179 markers of Th2 inflammation, reducing serum immunoglobulin E (IgE), chemokine ligands 13 and 17 by a

180 r, the level of a systemic Th2 marker, serum immunoglobulin E (IgE), correlated significantly with SR

181 cells by phosphorylation of the receptor for immunoglobulin E (IgE), FcepsilonRI, by Lyn kinase after

182 g by antigen, the high affinity receptor for immunoglobulin E (IgE), FcepsilonRI, is phosphorylated b

183 y fever, allergic sensitization, serum total immunoglobulin E (IgE), forced expiratory volume in one-

184 of allergens, and geometric mean serum total immunoglobulin E (IgE), in 3451 participants aged 18-75

185 lpha), IL-6, IL-12/23, IL-17, IL-4/13, IL-5, immunoglobulin E (IgE), integrins and B cells.

186 We know now that this factor is immunoglobulin E (IgE), sensitizing mast cells and basop

187 The distinguishing structural feature of immunoglobulin E (IgE), the antibody responsible for all

188 We identified unique signatures for AD (Immunoglobulin E (IgE), thymus- and activation-regulated

189 Their activation via immunoglobulin E (IgE)-antigen interactions is promoted

190 orm of treatment for patients suffering from immunoglobulin E (IgE)-associated allergy; the most comm

191 parvalbumin, which was shown to have reduced immunoglobulin E (IgE)-binding capacity upon calcium dep

192 ophil IL-4 production after stimulation with immunoglobulin E (IgE)-containing immune complexes.

193 f LPA were functional, as evidenced by their immunoglobulin E (IgE)-dependent histamine release and b

194 The structure of immunoglobulin E (IgE)-Fc(3-4) has been solved in three

195 an emphasis on novel FcepsilonRI regulators, immunoglobulin E (IgE)-independent pathways [e.g., Mas-r

196 during pregnancy may reduce the incidence of immunoglobulin E (IgE)-mediated allergic disease.

197 Immunoglobulin E (IgE)-mediated anaphylaxis is a potenti

198 of intracellular calcium concentration upon immunoglobulin E (IgE)-mediated crosslinking of the high

199 Atopic or immunoglobulin E (IgE)-mediated diseases include the com

200 Atopy is characterized by immediate immunoglobulin E (IgE)-mediated hypersensitivity to agen

201 psilonRI beta chain, a molecule important in immunoglobulin E (IgE)-mediated immunity.

202 Classical itch studies have focused on immunoglobulin E (IgE)-mediated mast cell activation and

203 Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled all

204 a consequence of antigen-aggregation of the immunoglobulin E (IgE)-occupied high affinity receptor f

205 Immunoglobulin E (IgE)-sensitization to peanut is common

206 ndent on the acquisition of antigen-specific immunoglobulin E (IgE).

207 bited increased blood levels of Ova-specific immunoglobulin E (IgE).

208 nificant reduction in peanut specific plasma Immunoglobulin E (IgE).

209 y allergen in complex with allergen-specific immunoglobulin E (IgE).

210 erized by substantial increases in levels of immunoglobulin E (IgE).

211 immunoglobulin class switch-recombination to immunoglobulin E (IgE).

212 sthma, atopic dermatitis, and elevated total immunoglobulin E (IgE).

213 llergic reactions that are often mediated by immunoglobulin E (IgE).

214 nsitivity (DTH) to SEA; high levels of serum immunoglobulin E (IgE); a strong T2 cytokine phenotype w

215 ation through the high-affinity receptor for immunoglobulin E (IgE; FcepsilonRI).

216 The initiation of immunoglobulin-E (IgE)-mediated allergic responses requi

217 Immunoglobulins E (IgEs) trigger allergic reactions by s

218 tood, the disease is mediated by an abnormal immunoglobulin-E immune response in the setting of skin

219 Cat- and cockroach-sensitive (immunoglobulin E immunocap [Cap] class > or = 1) women w

220 complete lack of prevailing Sm-p80-specific immunoglobulin E in a high-risk or infected population w

221 maternal parasitemia and levels of PLAP and immunoglobulin E in cord blood.

222 gen-specific serum immunoglobulins and total immunoglobulin E in different groups of animals were mea

223 ecurrent respiratory infections and elevated immunoglobulin E in serum.

224 sis in the jejunum and had reduced ovalbumin-immunoglobulin E in their serum, compared with TSLPR(+/+

225 These studies highlight a mast cell- and immunoglobulin E-independent role for CCR6-bearing T cel

226 essential role in antigen sensitization and immunoglobulin E induction, stimulate dendritic cell acc

227 Also, substantial reductions in plasma total immunoglobulin E, interleukin (IL)-1beta, and tumor necr

228 nificantly correlated with decrease in total immunoglobulin E level (rho = 0.47; P = .04).

229 can data set and incorporate the total serum immunoglobulin E level in the analysis.

230 rd the T helper 2 type, with increased total immunoglobulin E levels (P<.06) and a tendency toward in

231 OVA-specific Th1 to Th2 cells and decreased immunoglobulin E levels after allergen challenge as adul

232 antigen treatments resulted in reduced total immunoglobulin E levels and peripheral blood eosinophil

233 g doxorubicin and trastuzumab, high baseline immunoglobulin E levels are associated with a lower risk

234 tions between multiple VDR polymorphisms and immunoglobulin E levels were also observed (p = 0.006-0.

235 l alkaline phosphatase (PLAP) and polyclonal immunoglobulin E levels were also quantified in paired m

236 h doxorubicin and trastuzumab, high baseline immunoglobulin E levels were associated with a significa

237 Serum immunoglobulin E levels were increased in IL-13Ralpha2-/

238 4 production by NKT cells, to increase serum immunoglobulin E levels, and to promote the generation o

239 urrent viral and bacterial infections, hyper-immunoglobulin E levels, eczema, and greater susceptibil

240 allenge with ovalbumin, as measured by total immunoglobulin E levels, ovalbumin-specific immunoglobul

241 iotemporal dynamics of the redistribution of immunoglobulin E-loaded receptors (IgE-FcepsilonRI) on r

242 etion of cytokines involved in regulation of immunoglobulin E, mast cells, basophils and eosinophils,

243 lower immunoglobulin A (median, 1:3,200) and immunoglobulin E (median, 1:128) titers to rAls3p-N by e

244 Hypersensitivity Immunoglobulin E mediated syndromes are primary immunode

245 ceptor (FcepsilonRI) complex is dedicated to immunoglobulin E-mediated allergic responses.

246 ted with traits underlying asthma and atopy (immunoglobulin E-mediated allergy).

247 d mouse mast cells inhibited antigen-induced immunoglobulin E-mediated cell activation.

248 tive incidence to be 0.34% by 1 year of age; immunoglobulin E-mediated cow's milk allergy was 0.5%.

249 Rgs13-/- mice had enhanced immunoglobulin E-mediated mast cell degranulation and an

250 Mast cells contribute to immunoglobulin-E-mediated allergic disorders including a

251 rvoir after antigen capture through specific immunoglobulin E molecules bound to their FcepsilonRI.

252 Omalizumab, an anti-immunoglobulin E monoclonal antibody, has transformed th

253 FcepsilonRI, the high-affinity receptor for immunoglobulin E, on RBL-2H3 mast cells results in its c

254 was not apparent following plate-bound anti-immunoglobulin E or SEA stimulation.

255 Allergen-specific immunoglobulin E (present in allergic sensitization) has

256 y enhanced type 2 responses (IL-4, IL-5, and immunoglobulin E production) upon in vitro TCR stimulati

257 mal allergen-induced airway hyperreactivity, immunoglobulin E production, mucus metaplasia, and airwa

258 reduced T2 cytokine production and no serum immunoglobulin E production.

259 Furthermore, enhancement of immunoglobulin-E production and dermatitis by delta-toxi

260 inst the protein extracts revealed different Immunoglobulin E reactivity of sera according to the ins

261 sera from soybean-sensitive individuals have immunoglobulin E reactivity to abundant storage proteins

262 d performed serological analyses of specific immunoglobulin E reactivity.

263 these cells, cross-linking the high-affinity immunoglobulin E receptor (FcepsilonR1) leads to activat

264 The high affinity immunoglobulin E receptor (FcepsilonRI) complex is dedic

265 mediators after antigen crosslinking of the immunoglobulin E receptor FcepsilonRI.

266 f macrophages that express the high-affinity immunoglobulin E receptor FcepsilonRIalpha and are in cl

267 on when RBL-2H3 cells are stimulated via the immunoglobulin E receptor, Fc epsilon RI.

268 CD23, the low-affinity immunoglobulin E receptor, is an important modulator of

269 lso showed functional defects; high-affinity immunoglobulin E receptor-mediated degranulation was sig

270 tive [Lin-]/CD34hi/CD117int/hi/high-affinity immunoglobulin E receptor-positive [FcepsilonRI+]), with

271 We find that antigen stimulation of immunoglobulin E receptors causes much less Orai1/CRACM1

272 (IL)-4 and IL-5 and posttreatment levels of immunoglobulin E recognizing the parasite's tegument (Te

273 Robert L. Coffman recounts how his work on immunoglobulin E regulation along with data from Tim Mos

274 duce iBALTs, which coincided with subsequent immunoglobulin E responses, and IL-1-receptor-deficient

275 Immunoglobulin E sensitization was almost exclusively di

276 d treatments of asthma, rhinitis and eczema; immunoglobulin E sensitization; weight; and height.

277 disease, which is frequently associated with immunoglobulin-E sensitization to ubiquitous fungi, typi

278 rgies were excluded by negative results from immunoglobulin E serology analysis and skin tests for co

279 ences in the number of sensitizations, total immunoglobulin E serum levels and predilection of the sk

280 termined by skin prick tests (SPT); specific immunoglobulin E (sIgE) titers against 12 common allerge

281 story rates and peanut- and Ara h 2-specific immunoglobulin E (sIgE) titers were significantly higher

282 to analyze the diagnostic value of specific immunoglobulin E (sIgE) to Gly m 2S albumin, Gly m 4, 5,

283 e, history, skin prick test, peanut specific immunoglobulin E (sIgE), and total IgE minus peanut sIgE

284 s leads to diseases such as cancer and hyper-immunoglobulin E syndrome (HIES).

285 efit from targeted anti-interleukin and anti-immunoglobulin E therapies, and in monitoring subsequent

286 ts for seasonal allergic rhinitis, and alpha-immunoglobulin E therapy for asthma.

287 om inhaled corticosteroids and targeted anti-immunoglobulin E therapy.

288 hacholine (MTCH)-challenge test, serum total immunoglobulin E (TIgE), serum-specific immunoglobulin E

289 immunoglobulin E levels, ovalbumin-specific immunoglobulin E titers, and eosinophil content of bronc

290 sing allergic lung inflammation and elevated immunoglobulin E titers.

291 Specific immunoglobulin E to Gly m 2S albumin had the best accura

292 Specific immunoglobulin E to Gly m 2S albumin had the highest AUC

293 re added, with oral corticosteroids and anti-immunoglobulin E treatment with omalizumab for the most

294 Immunoglobulin E-triggered anaphylactic responses, inclu

295 in serum antigen-specific immunoglobulin G1/immunoglobulin E using ovalbumin or Aspergillus fumigatu

296 d gel-phase membranes displaying ligands for immunoglobulin E, using total internal reflection fluore

297 Immunoglobulin E was lower in children with measles, des

298 kers of oxidative stress, thromboxane B2 and immunoglobulin E were measured in bronchoalveolar lavage

299 alloproteinase-9 total, apolipoprotein E and immunoglobulin E--were used along with co-variates in mu

300 t differences between cases and controls was immunoglobulin E, with higher levels detected at baselin